key: cord-0844782-hc6nr552
authors: Wong, Ian Chi Kei; Wan, Eric Yuk Fai; Chui, Celine Sze Ling; Li, Xue; Chan, Esther Wai Yin
title: Adverse event reporting and Bell's palsy risk after COVID-19 vaccination – Authors' reply
date: 2021-10-28
journal: Lancet Infect Dis
DOI: 10.1016/s1473-3099(21)00631-9
sha: 35734bb59a469e05f541706684f2ea1782fc0e00
doc_id: 844782
cord_uid: hc6nr552

nan

alternative study design for drug safety studies. 2 It was specifically developed to evaluate vaccine safety with the advantage of reducing unmeasured confounding through the comparisons within individuals. 3, 4 Because of the small number of events and a short follow-up period in our study, we were unable to apply such a method. We appreciate Chang and Kong's interest in our study and, as stated in our paper, further study is warranted to confirm our findings. might be relatively better than the health of our control participants. A possible reason is that relatively healthy individuals with high-risk occupations were given priority for vaccination in the rollout schedule of the vaccination programme in Hong Kong, which is included in our study. 2 We addressed this issue in our analysis by adjusting baseline characteristics, including comorbidities and concurrent medication use. There fore, such characteristics should not have had a significant effect on our results or conclusions.

To further address Chang and Kong's concern on the difference in baseline characteristics between cases and controls, 1 we conducted further post-hoc sensitivity analysis by excluding control participants with neoplasms or exposure to antibacterial drugs because there were substantial differences between cases and controls (neoplasm 5% vs 13%; antibacterial drugs 7% vs 13%). 1 The results were similar to the main findings (table), which further supports the robustness of our study.

As is the case for all observational studies, the effect of unmeasured confounding in our nested casecontrol study cannot be completely ruled out. The self-controlled case series method has become a popular

Kwok-Chiu Chang and Fuk-Yip Kong suggest that possible selection bias in our nested case-control study could be due to the control participants (ie, patients admitted to emergency rooms or hospital wards) being older than all participants eligible for vaccination in the general population. However, as we used a matched casecontrol study design, this concern is irrelevant. As stated in our methods, we matched each case with a control using the exact year of age in our analysis. Hence, the hypothetical example for potential selection bias referred to by Chang and Kong does not apply to our study.

We acknowledge that the health of participants eligible for vaccination 

Cases and controls were matched according to age, sex, setting, and admission date. Odds ratios for Bell's palsy were estimated by conditional logistic regression adjusted for smoking status, pre-existing comorbidities (ie, diabetes, hypertension, asthma, rheumatoid arthritis, stroke, and migraine), infections in the past 90 days (acute respiratory infections), and medication use in the past 90 days (antiviral drugs, systemic corticosteroids, immunosuppressants). *Three patients were excluded as the corresponding control participants were excluded because of neoplasms or the antibacterial drugs used. We adapted our agent-based model of SARS-CoV-2 transmission 2,3 to the demography, contact patterns, and age-stratified vaccination tra jectories of Florida and Texas. We further accounted for the emergence and spread of the alpha (B.1.1.7), gamma (P.1), iota (B.1.526), and delta variants, in addition to the original strain. 2,3 Vaccine efficacies against infection and symptomatic and severe disease for different vaccine types, each variant, and by vaccine dosage were parameterised from clinical studies (appendix pp 4-5). The model was calibrated to the reported incidence in each state between Oct 1, 2020, and Aug 31, 2021 (appendix p 6). Using the calibrated model, we evaluated the impact of enhanced vaccination rollout by scaling the daily vaccine doses distributed to achieve 74·0% cover age of fully vaccinated adults by July 31, 2021, and continued with the associated daily rates of vaccine rollout. We then simulated the epidemiological trajectories of outbreaks in Florida and Texas and compared them with the observed cases, hospital admissions, and deaths in these two states from Dec 12, 2020, to Aug 31, 2021.

We found that enhanced vaccination would have markedly blunted the increase in cases, hospital admissions, and deaths in Florida and Texas EWYC reports honorarium from Hospital

In July, 2021, another wave of COVID-19 began in the USA as the highly infectious delta (B.1.617.2) SARS-CoV-2 variant drove outbreaks predominantly affecting states with relatively low 

vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study

Association between methylphenidate treatment and risk of seizure: a population-based, self-controlled case-series study

Tutorial in biostatistics: the self-controlled case series method

Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice